RE:RE:Very interesting---2b7f6fab wrote:
With the latest news release of activation using Metformin, if true, I'm tripling my minimum target buyout price to $10 billion. Think of how cheap and simple it would be to run the bladder cancer trial using metformin instead of laser activation. The screw up with the first twelve would not have happened and even deep seated muscle invasive cancers and kidney/ureter tumors would have been treated. Had this activation been known previously instead of trialling bladder cancer they could have gone directly at lung, breast, brain, colon, pancreatic etc cancers. bwdik, glta
That's my thinking also. That would be a great bargain though; It's worth a lot more. In the end, it'll be fair for everyone.